Bharat Biotech

Pembangun vaksin Bharat Biotech menerbitkan data yang menunjukkan keberkesanan vaksin itu mencecah 78 peratus.

Data menunjukkan perlindungan 65.2 peratus terhadap varian Delta yang pertama kali dikesan di India dan menyebabkan lonjakan kes pada April dan Mei lalu.

Bolsonaro said the price for the Bharat vaccines was broadly in line with other countries.

Barely 3 pct of India's 1.3 billion people have been vaccinated, the lowest rate among the 10 countries with the most cases.

Polis menemui lori berkenaan yang membawa 364 kotak bekalan vaksin 'Covaxin' keluaran Bharat Biotech bernilai AS$1.08 juta.

Modi's government would instead aim to support domestic vaccine makers by guaranteeing purchases from them.

India is currently administering AstraZeneca's COVID-19 vaccine, manufactured by SII and delevoped by Bharat Biotech called COVAXIN.

The government blames the resurgence mainly on crowding and a reluctance to wear masks as shops and offices have reopened.

A rundown of the most important stories you need to know for the day, from the newsroom of Astro AWANI.

Government data shows that only 10% of about 12.6 million people immunised in India have taken the COVAXIN shot.

People above 60, and those who are 45 or more and suffering from certain medical conditions, are now eligible for the vaccinations.

A lack of confidence in a homegrown vaccine country could prevent India from meeting its target of vaccinating 300 million people by August.

India's huge coronavirus vaccination drive is behind schedule, hampered by technical glitches and safety fears.

India is also exporting doses to Brazil and Morocco, and free shipments to the Maldives, Bhutan, Bangladesh and Nepal.

If allowed to go ahead, this would be the first trial of any coronavirus vaccine in Bangladesh.